Authors:
TSOUKAS CM
RABOUD J
BERNARD NF
MONTANER JSG
GILL MJ
RACHLIS A
FONG IW
SCHLECH W
DJURDJEV O
FREEDMAN J
THOMAS R
LAFRENIERE R
WAINBERG MA
CASSOL S
OSHAUGHNESSY M
TODD J
VOLVOVITZ F
SMITH GE
Citation: Cm. Tsoukas et al., ACTIVE IMMUNIZATION OF PATIENTS WITH HIV-INFECTION - A STUDY OF THE EFFECT OF VAXSYN, A RECOMBINANT HIV ENVELOPE SUBUNIT VACCINE, ON PROGRESSION OF IMMUNODEFICIENCY, AIDS research and human retroviruses, 14(6), 1998, pp. 483-490
Authors:
LEW J
REICHELDERFER P
FOWLER M
BREMER J
CARROL R
CASSOL S
CHERNOFF D
COOMBS R
CRONIN M
DICKOVER R
FISCUS S
HERMAN S
JACKSON B
KORNEGAY J
KOVACS A
MCINTOSH K
MEYER W
MICHAEL N
MOFENSON L
MOYE J
QUINN T
ROBB M
VAHEY M
WEISER B
YEGHIAZARIAN T
Citation: J. Lew et al., DETERMINATIONS OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - REASSESSMENT OF PARAMETERS AFFECTING ASSAY OUTCOME, Journal of clinical microbiology, 36(6), 1998, pp. 1471-1479
Authors:
CASSOL S
GILL MJ
PILON R
CORMIER M
VOIGT RF
WILLOUGHBY B
FORBES J
Citation: S. Cassol et al., QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM DRIED PLASMA SPOTS COLLECTED ON FILTER-PAPER, Journal of clinical microbiology, 35(11), 1997, pp. 2795-2801
Authors:
RABOUD JM
MONTANER JSG
THORNE A
SINGER J
SCHECHTER MT
RACHLIS A
GILL J
BEAULIEU R
TSOUKAS C
FANNING M
CAMERON W
LALONDE R
BERGERON M
SCHLECH W
SALIT I
PHILLIPS P
SALOMON H
SPIRA B
CONWAY B
AUCLAIR C
CASSOL S
OSHAUGHNESSY MV
WAINBERG MA
Citation: Jm. Raboud et al., IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 46-55
Authors:
CASSOL S
WENIGER BG
BABU PG
SALMINEN MO
ZHENG XW
HTOON MT
DELANEY A
OSHAUGHNESSY M
OU CY
Citation: S. Cassol et al., DETECTION OF HIV TYPE-1 ENV SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E IN ASIA USING DRIED BLOOD SPOTS - A NEW SURVEILLANCE TOOL FOR MOLECULAR EPIDEMIOLOGY, AIDS research and human retroviruses, 12(15), 1996, pp. 1435-1441
Authors:
TSOUKAS CM
RABOUD J
BERNARD N
DJURDJEV O
CASSOL S
CHERNOFF D
FONG I
FREEDMAN J
GILL J
GOLDBERG E
LAFRENIERE R
LEE S
MONTANER J
POON MC
RACHLIS A
SCHLECH W
SMITH G
SZABO J
TODD J
THOMAS R
VOLVOVITZ F
Citation: Cm. Tsoukas et al., THERAPEUTIC VACCINATION - A RANDOMIZED CONTROLLED-STUDY OF THE EFFECTOF RGP160 ON PROGRESSION OF IMMUNE-DEFICIENCY AND VIRAL BURDEN, AIDS, 10, 1996, pp. 62-62
Authors:
JANET R
TSOUKAS C
BERNARD N
DJURDJEV O
CASSOL S
CHERNOFF D
FONG I
FREEDMAN J
GILL J
GOLDBERG E
LAFRENIERE R
LEE S
MONTANER J
POON MC
RACHLIS A
SCHLECH W
SMITH G
SZABO J
TODD J
THOMAS R
VOLVOVITZ F
Citation: R. Janet et al., PLASMA VIREMIA IS MORE PREDICTIVE OF DISEASE PROGRESSION THAN CD4 COUNTS IN HIV-INFECTED INDIVIDUALS WITH CD4 COUNTS GREATER-THAN 500 IN A RANDOMIZED TRIAL OF IMMUNIZATION WITH RGP160, AIDS, 10, 1996, pp. 63-63
Authors:
CHOU L
BOUSTANY F
NATHANSON D
EPSTEIN J
CASSOL S
Citation: L. Chou et al., G-]A HYPERMUTATION IN ENV LOOP V2 REGION OF HIV-1 GENE IN ORAL HAIRY LEUKOPLAKIA, Journal of dental research, 75, 1996, pp. 778-778
Authors:
MERZOUKI A
PATEL P
CASSOL S
ENNAJI M
TAILOR P
TURCOTTE FR
OSHAUGHNESSY M
ARELLA M
Citation: A. Merzouki et al., HIV-1 GP120 160 EXPRESSING CELLS UP-REGULATE HIV-1 LTR DIRECTED GENE-EXPRESSION IN A CELL-LINE TRANSFECTED WITH HIV-1 LTR - REPORTER GENE CONSTRUCTS/, Cellular and molecular biology, 41(3), 1995, pp. 445-452
Authors:
MONTANER JSG
SCHECHTER MT
RACHLIS A
GILL J
BEAULIEU R
TSOUKAS C
RABOUD J
CAMERON B
SALOMON H
DUNKLE L
SMALDONE L
WAINBERG MA
FANNING M
LALONDE R
BERGERON M
SCHLECH W
SALIT I
PHILLIPS P
SPIRA B
CONWAY B
CASSOL S
OSHAUGNESSY M
THORNE A
SINGER J
AUCLAIR C
Citation: Jsg. Montaner et al., DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/, Annals of internal medicine, 123(8), 1995, pp. 561-571
Authors:
SHEN YN
RUDNIK J
CASSOL S
DROUIN J
CAMERON W
IZAGUIRRE CA
FILION LG
Citation: Yn. Shen et al., BLOOD MONOCYTES FROM MOST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS DO NOT CARRY PROVIRAL DNA, Clinical and diagnostic laboratory immunology, 1(5), 1994, pp. 531-537
Authors:
MERZOUKI A
MO T
VELLANI N
PATTULLO A
ESTABLE M
OSHAUGHNESSY M
TSOUKAS C
CASSOL S
Citation: A. Merzouki et al., ACCURATE AND DIFFERENTIAL QUANTITATION OF HIV-1 TAT, REV AND NEF MESSENGER-RNAS BY COMPETITIVE PCR, Journal of virological methods, 50(1-3), 1994, pp. 115-128
Authors:
MERZOUKI A
PATEL P
CASSOL S
OSHAUGHNESSY M
GILL J
ARELLA M
Citation: A. Merzouki et al., HIV-1 GP120 160 EXPRESSING TRANSFECTED CELL CLONES TO EVALUATE THE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) DURING THE COURSE OF HIV-1 INFECTION/, Journal of virological methods, 48(1), 1994, pp. 9-21
Authors:
CASSOL S
BUTCHER A
KINARD S
SPADORO J
SY T
LAPOINTE N
READ S
GOMEZ P
FAUVEL M
MAJOR C
OSHAUGHNESSY M
Citation: S. Cassol et al., RAPID SCREENING FOR EARLY DETECTION OF MOTHER-TO-CHILD TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of clinical microbiology, 32(11), 1994, pp. 2641-2645
Authors:
COUTLEE F
OLIVIER C
CASSOL S
VOYER H
KESSOUSELBAZ A
SAINTANTOINE P
HE YL
FAUVEL M
Citation: F. Coutlee et al., ABSENCE OF PROLONGED IMMUNOSILENT INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS IN INDIVIDUALS WITH HIGH-RISK BEHAVIORS, The American journal of medicine, 96(1), 1994, pp. 42-48